Literature DB >> 7538058

Plastic-covered metallic endoprostheses in the management of oesophageal perforation in patients with oesophageal carcinoma.

A Watkinson1, J Ellul, K Entwisle, M Farrugia, R Mason, A Adam.   

Abstract

OBJECTIVE: To evaluate the role of plastic-covered self-expanding metallic endoprostheses in patients with oesophageal perforation occurring during endoscopically guided dilatation prior to laser treatment for malignant obstruction. SUBJECTS AND METHODS: Six patients with oesophageal perforation following laser treatment for malignant obstruction were treated. Four patients received the polyurethane-covered Wallstent endoprosthesis (Schneider SA, Bulach, Switzerland) and two patients the barbed polyethylene-covered Gianturco stent (William Cook, Europe).
RESULTS: All patients had successful stent placement under intravenous sedation and fluoroscopic guidance with immediate relief of dysphagia and sealing of the perforation. Following the procedure all patients could eat either a normal diet or soft food and five patients were discharged within 3-4 days. None of the serious sequelae usually associated with oesophageal perforation were observed. Two patients required second overlapping stents to be inserted within 1 week because of minor migration of the initial endoprostheses. In one patient two stents were necessary because the carcinoma extended over 17 cm. Five patients died after stent insertion (mean survival time = 49 days, range 16-80; median survival time = 37 days, range 16-80) due to a general deterioration in their condition, although all could swallow normally until death. The remaining patient was well and tolerating a light diet at 1 month.
CONCLUSION: This technique is quick, safe and cost-effective and is now our preferred method of managing malignant oesophageal obstruction associated with perforation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7538058     DOI: 10.1016/s0009-9260(05)83421-x

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  11 in total

1.  Guidelines for the management of oesophageal and gastric cancer.

Authors:  W H Allum; S M Griffin; A Watson; D Colin-Jones
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

2.  Insertion of self-expanding metal stents for malignant dysphagia: assessment of a simple endoscopic method.

Authors:  R Singhvi; F Abbasakoor; J M Manson
Journal:  Ann R Coll Surg Engl       Date:  2000-07       Impact factor: 1.891

3.  Iatrogenic oesophageal perforations: a clinical review.

Authors:  D M Gold; P H Rowe
Journal:  Ann R Coll Surg Engl       Date:  1998-07       Impact factor: 1.891

4.  A novel method for the treatment of localised intrathoracic anastomotic leakage.

Authors:  J S Jameson; J Boyle; W M Thomas; P S Veitch
Journal:  Ann R Coll Surg Engl       Date:  1996-05       Impact factor: 1.891

5.  Palliation of malignant esophageal obstruction and fistulas with self expandable metallic stents.

Authors:  Ahmet Dobrucali; Erkan Caglar
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

6.  Palliation of malignant dysphagia: an alternative to surgery.

Authors:  R Mason
Journal:  Ann R Coll Surg Engl       Date:  1996-09       Impact factor: 1.891

7.  Esophageal stenting.

Authors:  Andrew S Lowe; Maria B Sheridan
Journal:  Semin Intervent Radiol       Date:  2004-09       Impact factor: 1.513

8.  Expandable stents for iatrogenic perforation of esophageal malignancies.

Authors:  Russell E White; Caesar Mungatana; Mark Topazian
Journal:  J Gastrointest Surg       Date:  2003 Sep-Oct       Impact factor: 3.452

9.  Gastrointestinal symptomatic outcome after laparoscopic Roux-en-Y gastric bypass.

Authors:  Allen Foster; Henry L Laws; Quintin H Gonzalez; Ronald H Clements
Journal:  J Gastrointest Surg       Date:  2003 Sep-Oct       Impact factor: 3.452

10.  Self-expanding metal stents in palliation of malignant dysphagia: outcome of 124 Egyptian patients.

Authors:  Asser Abdel Raouf Elsharkawy; A A El-Geidie
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-01-13       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.